切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2023, Vol. 17 ›› Issue (05) : 580 -583. doi: 10.3877/cma.j.issn.1674-3946.2023.05.028

论著

腹腔镜肝切除联合断面射频消融治疗伴微血管侵犯肝细胞癌的临床研究
王兴, 张峰伟()   
  1. 710038 西安,西安医学院第二附属医院肝胆外科
    710038 西安,西安医学院第二附属医院心血管外科
  • 收稿日期:2022-07-13 出版日期:2023-10-26
  • 通信作者: 张峰伟

Clinical study of laparoscopic hepatectomy combined with radiofrequency ablation in the treatment of hepatocellular carcinoma with microvascular invasion

Xing Wang, Fengwei Zhang()   

  1. Department of Hepatobiliary Surgery, the Second Affiliated Hospital of Xi’an Medical College, Xi’an Shaanxi Province 710038, China
    Department of Cardiovascular Surgery, the Second Affiliated Hospital of Xi’an Medical College, Xi’an Shaanxi Province 710038, China
  • Received:2022-07-13 Published:2023-10-26
  • Corresponding author: Fengwei Zhang
引用本文:

王兴, 张峰伟. 腹腔镜肝切除联合断面射频消融治疗伴微血管侵犯肝细胞癌的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2023, 17(05): 580-583.

Xing Wang, Fengwei Zhang. Clinical study of laparoscopic hepatectomy combined with radiofrequency ablation in the treatment of hepatocellular carcinoma with microvascular invasion[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(05): 580-583.

目的

探讨腹腔镜肝切除术(LH)联合断面射频消融(RFA)治疗伴有微血管侵犯(MVI)肝细胞癌(HCC)的临床效果。

方法

回顾性选取2018年6月至2020年6月接受常规LH治疗和LH联合断面RFA治疗的伴有MVI的HCC患者各28例,根据不同治疗方法分为常规组(行LH治疗)和联合组(行LH联合断面RFA治疗)。采用统计学软件SPSS 22.0分析,两组患者围手术期相关指标、肝功能指标计量资料采用(

x¯
±s)表示,采用独立样本t检验或方差检验;术后并发症计数资料采用[例(%)]表示,行χ2检验,等级资料行秩和检验;生存分析采用Log-Rank检验。P<0.05为差异有统计学意义。

结果

联合组患者术后24 h腹腔血性引流液较常规组显著降低,住院费用显著升高(P<0.05)。时间与方法在ALB、AST、TBIL、ALT水平上不存在交互作用(P>0.05),时间在ALB、AST、TBIL、ALT水平上主效应显著(P<0.05),方法在ALB、AST、TBIL、ALT水平上主效应不显著(P>0.05)。两组患者术后并发症总发生率比较(32.1% vs. 21.4%),差异无统计学意义(P>0.05)。随访期间,通过Kaplan-Meier分析显示,联合组患者累积总生存率(71.4% vs.50.0%)及无病生存率(64.3% vs.42.9%)均显著高于常规组,差异有统计学意义(Log-Rank χ2=4.099、4.710,P=0.043、0.030)。

结论

LH联合断面RFA治疗伴有MVI的HCC虽然住院费用略高,但其安全可行,并最大程度上保障了患者术后肝功能,改善了患者预后。

Objective

To investigate the clinical effect of laparoscopic hepatectomy(LH)combined with radiofrequency ablation(RFA)in the treatment of hepatocellular carcinoma(HCC)with microvascular invasion(MVI).

Methods

Twenty-eight MVI patients with HCC who received conventional LH treatment and RFA treatment with LH combination section from June 2018 to June 2020 were retrospectively selected and divided into conventional group and combination group according to treatment method. Statistical software SPSS 22.0 was used to analyze the measurement data of perioperative relevant indicators and liver function indicators of the two groups(

x¯
±s),and independent sample t test or Variance test was used. The adoption rate of postoperative complications count data(%)was indicated by χ2 test and Rank Sum test. Survival analysis was performed by Log-Rank test. P<0.05 was considered statistically significant.

Results

The blood drainage in the combined group was significantly lower than that in the conventional group 24 hours after operation,and the hospitalization cost was significantly increased(P<0.05). There was no interaction between time and method at ALB,AST,TBILand ALT levels(P>0.05),and the main effect of time was significant at ALB,AST,TBIL and ALT levels(P<0.05),while the main effect of method was not significant at ALB,AST,TBIL and ALT levels(P>0.05). There was no significant difference in the total incidence of postoperative complications between the two groups(32.1%vs.21.4%)(P > 0.05). During the follow-up period,Kaplan-Meier analysis showed that the cumulative overall survival rate(71.4%vs.50.0%)and disease-free survival rate(64.3%vs.42.9%)of the combined group were significantly higher than those of the conventional group,and the difference was statistically significant(Log-Rank χ2 =4.099,4.710,P=0.043,0.030).

Conclusion

Although the hospitalization cost of LH combined with sectional RFA for HCC accompanied by MVI is slightly higher,it is safe and feasible,and can guarantee the postoperative liver function of patients to the greatest extent and improve the prognosis of patients.

表1 56例伴有MVI的HCC不同手术方式两组患者一般资料[(
x¯
±s),例]
表2 56例伴有MVI的HCC不同手术方式两组患者围手术期相关指标(
x¯
±s)
表3 56例伴有MVI的HCC不同手术方式两组患者肝功能指标(
x¯
±s)
表4 56例伴有MVI的HCC不同手术方式两组患者术后并发症情况[例(%)]
图1 56例伴有MVI的HCC不同手术方式两组患者术后生存曲线
[16]
Elmahi ESalama YCadden F. A literature review to assess blood loss in minimally invasive liver surgery versus in open liver resection[J]. Cureus202113(6):e16008.
[1]
Xu TRen LLiao M,et al. Preoperative radiomics analysis of contrast-enhanced CT for microvascular invasion and prognosis stratification in hepatocellular carcinoma[J]. J Hepatocell Carcinoma20229:189-201.
[2]
于洁,段红亮,吴晓庆,等. 原发性肝细胞癌微血管侵犯的术前预测模型构建及临床意义[J/CD]. 中华普外科手术学杂志(电子版),202115(01):57-60.
[3]
Ma XWei JGu D,et al. Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT[J]. Eur Radiol201929(7):3595-3605.
[4]
Lee JShin ISYoon WS,et al. Comparisons between radiofrequency ablation and stereotactic body radiotherapy for liver malignancies:Meta-analyses and a systematic review[J]. Radiother Oncol2020145:63-70.
[5]
向磊,秦春宏,费书珂. 射频消融术治疗肝细胞癌的研究进展[J]. 国际外科学杂志201946(02):140-144.
[6]
张强,李恒平. TACE术联合RFA术对高危部位原发性肝癌的临床疗效分析[J/CD]. 中华普外科手术学杂志(电子版),202014(02):201-204.
[7]
中华人民共和国卫生和计划生育委员会医政医管局. 原发性肝癌诊疗规范(2017年版)[J]. 中华消化外科杂志201716(07):635-647.
[8]
Orcutt STAnaya DA. Liver Resection and Surgical Strategies for Management of Primary Liver Cancer[J]. Cancer Control201825(1):1073274817744621.
[9]
何涛,蒋禹,李秋,等. 肝细胞癌微血管侵犯的预测及治疗进展[J]. 临床肝胆病杂志202036(05):1185-1189.
[10]
沈锋,邹奇飞,范明明,等. 中国腹腔镜肝癌切除术20年发展、问题与对策[J/CD]. 中华普外科手术学杂志(电子版),202115(04):369-373.
[11]
于洪钧,柯善嘉,麻勇. 腹腔镜肝切除手术治疗肝细胞癌的若干问题探讨[J]. 国际外科学杂志202148(04):220-225.
[12]
Lee SKang TWSong KD,et al. Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation[J]. Ann Surg2021273(3):564-571.
[13]
白秀梅,杨薇. 射频消融治疗肝细胞癌的预后因素及研究新进展[J]. 世界华人消化杂志202129(13):677-683.
[14]
Jin STan SPeng W,et al. Radiofrequency ablation versus laparoscopic hepatectomy for treatment of hepatocellular carcinoma:a systematic review and meta-analysis[J]. World J Surg Oncol202018(1):199.
[15]
朱建平,余国华,薛晨辉,等. 原发性肝癌切除术中联合残肝断面射频消融对术后局部复发的预防[J]. 世界华人消化杂志202028(13):526-531.
[1] 燕速, 霍博文. 腹腔镜食管胃结合部腺癌根治性切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 13-13.
[2] 母德安, 李凯, 张志远, 张伟. 超微创器械辅助单孔腹腔镜下脾部分切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 14-14.
[3] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[4] 李子禹, 卢信星, 李双喜, 陕飞. 食管胃结合部腺癌腹腔镜手术重建方式的选择[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 5-8.
[5] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[6] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[7] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[8] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[9] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[10] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[11] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[12] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[13] 王庆亮, 党兮, 师凯, 刘波. 腹腔镜联合胆道子镜经胆囊管胆总管探查取石术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 313-313.
[14] 杨建辉, 段文斌, 马忠志, 卿宇豪. 腹腔镜下脾部分切除术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 314-314.
[15] 叶劲松, 刘驳强, 柳胜君, 吴浩然. 腹腔镜肝Ⅶ+Ⅷ段背侧段切除[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 315-315.
阅读次数
全文


摘要